CORONA Remedies Limited has been served a Demand Notice by the National Pharmaceutical Pricing Authority (NPPA) for an alleged violation of the Drugs (Prices Control) Order, 2013. The total demand amounts to ₹4,87,97,160, including interest and penalty. The company is currently evaluating the notice and will take appropriate steps in accordance with applicable laws, stating that the notice does not currently have a material financial impact.
NPPA Issues Demand Notice to CORONA Remedies
CORONA Remedies Limited announced on November 3, 2026, that it has received a Demand Notice from the National Pharmaceutical Pricing Authority (NPPA), an arm of the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India. This development falls under the purview of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Details of the Demand Notice
The Demand Notice, issued by NPPA, pertains to an alleged violation of Para 15 of the Drugs (Prices Control) Order, 2013 (DPCO 2013). The total amount demanded, inclusive of interest and penalty, is ₹4,87,97,160. The company stated that the issue relates to prior price approval under the DPCO 2013.
Company’s Response and Impact Assessment
CORONA Remedies is currently in the process of evaluating the demand notice and plans to undertake further actions to protect its interests, adhering to all applicable laws. As of the announcement, the company asserts that the said Demand Notice does not have any material financial impact on its operations.
Source: BSE
